Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Gilbert

Showing results (131-140 of 453) with videos related to

Pageof 46
Sort By:
Cancer Medicine|August 5, 2024
Identifying associations between sample characteristics, symptoms, and self-efficacy differences in adult patients with rare tumors of the central nervous system who participated in a novel web-based natural history studyAlvina Acquaye-Mallory, Elizabeth Vera, Anna Choi, et al.
Neuro-Oncology|April 22, 2010
Genetic variants in inflammation pathway genes and asthma in glioma susceptibilityE Amirian, Yanhong Liu, Michael E Scheurer, et al.
Journal of Neuro-Oncology|March 26, 2013
Outcomes for patients with anaplastic astrocytoma treated with chemoradiation, radiation therapy alone or radiation therapy followed by chemotherapy: a retrospective review within the era of temozolomideNicole A Shonka, Brett Theeler, Daniel Cahill, et al.
Neuro-Oncology|August 21, 2015
The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptomsTerri S Armstrong, Elizabeth Vera-Bolanos, Alvina A Acquaye, et al.
Journal of Neuro-Oncology|November 1, 2014
Symptoms and socio-economic impact of ependymoma on adult patients: results of the Adult Ependymoma Outcomes Project 2Tobias Walbert, Tito R Mendoza, Elizabeth Vera-Bolaños, et al.
Acta Neuropathologica|October 15, 2011
Recurrent PIK3CA mutations in rosette-forming glioneuronal tumorBenjamin Ellezam, Brett J Theeler, Rajyalakshmi Luthra, et al.
Journal of Neuro-Oncology|March 26, 2015
Significant predictors of patients' uncertainty in primary brain tumorsLin Lin, Lung-Chang Chien, Alvina A Acquaye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant gliomaMark R Gilbert, Jeffrey G Supko, Tracy Batchelor, et al.
Cancer|January 26, 2011
The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patientsTerri S Armstrong, Elizabeth Vera-Bolanos, Ibrahima Gning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Facing the future of brain tumor clinical researchMark R Gilbert, Terri S Armstrong, Whitney B Pope, et al.
Pageof 46

Showing results (131-140 of 453) with videos related to

Sort By:
Pageof 46
Cancer Medicine|August 5, 2024
Identifying associations between sample characteristics, symptoms, and self-efficacy differences in adult patients with rare tumors of the central nervous system who participated in a novel web-based natural history studyAlvina Acquaye-Mallory, Elizabeth Vera, Anna Choi, et al.
Neuro-Oncology|April 22, 2010
Genetic variants in inflammation pathway genes and asthma in glioma susceptibilityE Amirian, Yanhong Liu, Michael E Scheurer, et al.
Journal of Neuro-Oncology|March 26, 2013
Outcomes for patients with anaplastic astrocytoma treated with chemoradiation, radiation therapy alone or radiation therapy followed by chemotherapy: a retrospective review within the era of temozolomideNicole A Shonka, Brett Theeler, Daniel Cahill, et al.
Neuro-Oncology|August 21, 2015
The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptomsTerri S Armstrong, Elizabeth Vera-Bolanos, Alvina A Acquaye, et al.
Journal of Neuro-Oncology|November 1, 2014
Symptoms and socio-economic impact of ependymoma on adult patients: results of the Adult Ependymoma Outcomes Project 2Tobias Walbert, Tito R Mendoza, Elizabeth Vera-Bolaños, et al.
Acta Neuropathologica|October 15, 2011
Recurrent PIK3CA mutations in rosette-forming glioneuronal tumorBenjamin Ellezam, Brett J Theeler, Rajyalakshmi Luthra, et al.
Journal of Neuro-Oncology|March 26, 2015
Significant predictors of patients' uncertainty in primary brain tumorsLin Lin, Lung-Chang Chien, Alvina A Acquaye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant gliomaMark R Gilbert, Jeffrey G Supko, Tracy Batchelor, et al.
Cancer|January 26, 2011
The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patientsTerri S Armstrong, Elizabeth Vera-Bolanos, Ibrahima Gning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Facing the future of brain tumor clinical researchMark R Gilbert, Terri S Armstrong, Whitney B Pope, et al.
Pageof 46